期刊
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
卷 30, 期 12, 页码 1696-1704出版社
WILEY
DOI: 10.1111/jgh.13065
关键词
cell and molecular biology; EMMPRIN; hepatic inflammation; hepatology; liver fibrogenesis; liver immunobiology; liver regeneration; matrix metalloproteinases; stellate cell biology
Chronic liver disease causes significant morbidity and mortality through progressive fibrosis, cirrhosis, and liver cancer. The classical theory of fibrogenesis has hepatic stellate cells (HSCs) as the principal and only significant source of abnormal extracellular matrix (ECM). Further, HSCs have the major role in abnormal ECM turnover. It is the death of hepatocytes, as the initial target of injury, that initiates a sequence of events including the recruitment of inflammatory cells and activation of HSCs. Following this initial response, the ongoing insult to hepatocytes is regarded as perpetuating injury, but otherwise, hepatocytes are regarded as victims and bystanders in progressive fibrosis. Recent developments, however, challenge this view and suggest the concept of the hepatocyte being an active participant in liver injury. It is clear now that hepatocytes undergo phenotypic changes, adapt to injury, and react to the altered microenvironment. In this review, we describe studies showing that hepatocytes contribute to progressive fibrosis by direct manipulation of the surrounding ECM and through signaling to effector cells, particularly HSCs and intrahepatic immune cells. Together, these findings suggest an active accomplice role for the hepatocyte in progressive liver fibrosis and highlight novel pathways that could be targeted for development of future antifibrotic therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据